Refractory, primary Cutaneous T-Cell Non-Hodgkin Lymphoma
Also known as: Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB05015 | Belinostat | 1 | Not Yet Recruiting | 1 |
DB08870 | Brentuximab vedotin | 1 | Not Yet Recruiting | 1 |
DB08889 | Carfilzomib | 1 | Not Yet Recruiting | 1 |
DB09331 | Daratumumab | 1 | Not Yet Recruiting | 1 |
DB09502 | Fludeoxyglucose F-18 | 1 | Not Yet Recruiting | 1 |
DB00441 | Gemcitabine | 1 | Not Yet Recruiting | 1 |
DB00480 | Lenalidomide | 1 | Not Yet Recruiting | 1 |
DB09035 | Nivolumab | 1 | Not Yet Recruiting | 1 |
DB08935 | Obinutuzumab | 1 | Not Yet Recruiting | 1 |
DB09037 | Pembrolizumab | 1 | Not Yet Recruiting | 1 |
DB00073 | Rituximab | 1 | Not Yet Recruiting | 1 |
DB06176 | Romidepsin | 1 | Not Yet Recruiting | 1 |
DB06176 | Romidepsin | 1 | Recruiting | 1 |
DB00072 | Trastuzumab | 1 | Not Yet Recruiting | 1 |
DB08870 | Brentuximab vedotin | 2 | Recruiting | 1 |
DB00480 | Lenalidomide | 2 | Recruiting | 1 |
DB06132 | Nivolumab | 2 | Recruiting | 1 |
DB09035 | Nivolumab | 2 | Recruiting | 1 |
DB13896 | Talimogene laherparepvec | 2 | Recruiting | 1 |